Bayer hit with $332M verdict in Roundup trial

Bayer (BAYRY) slapped with $332M jury verdict in Roundup cancer trial. (00:29) Real estate stocks slump amid report NAR, brokerages guilty of collusion. (01:32) WeWork (WE) poised to file for Chapter 11 bankruptcy next week - report. (02:38)Episode transcripts seekingalpha.com/wsb.Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.Show links: Biggest stock movers today: Paycom Software, CRISPR Therapeutics and moreCRISPR, Vertex gene editing therapy gets warm response from FDA panelGenerative AI in 'very early days' for software giants like Microsoft, Salesforce - Deutsche BankU.S. automakers oppose Cleveland-Cliffs bid for U.S. Steel - reportTesla eyes producing 200,000 Cybertrucks annually - Elon Musk